KRH 1636

Known as: KRH-1636, KRH1636 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2015
01220032015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
We here report an experimentally verified binding mode for the known tripeptidomimetic CXCR4 antagonist KRH-1636 (1). A limited… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2011
2011
Understanding the structural mechanism of receptor-ligand interactions for the chemokine receptor CXCR4 is essential for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
The previously reported CXCR4 antagonist KRH-1636 was a potent and selective inhibitor of CXCR4-using (X4) human immunodeficiency… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2009
2009
CXC chemokine receptor-4, the receptor for stromal cell-derived factor-1alpha as well as human immunodeficiency virus type 1… (More)
Is this relevant?
2006
2006
Because of its involvement in HIV entry, the chemokine receptor CXCR4 is an attractive target for antiretroviral drugs. Despite… (More)
  • figure 1
  • table II
  • table III
  • figure 2
  • table IV
Is this relevant?
2004
2004
In recent years, significant progress has been made towards the chemotherapy (and ?prophylaxis) of HIV infections. This progress… (More)
Is this relevant?
2003
2003
A low molecular weight nonpeptide compound, KRH-1636, efficiently blocked replication of various T cell line-tropic (X4) HIV type… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?